TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30472037

Group type: EXPERIMENTAL
Intervention: 6-week exercise program with dietary intervention
Number of subjects: 57

Group type: COMPARATOR
Intervention: Sedentary control group
Number of subjects: 57
Study: 28867717

Group type: EXPERIMENTAL
Intervention: Prednisone (PRE)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Double-dose TWHF (DTW)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Conventional-dose TWHF (CTW)
Number of subjects: 49
Study: 26139585

Group type: EXPERIMENTAL
Intervention: Wii game computer with motivational support
Number of subjects: 600

Group type: COMPARATOR
Intervention: Motivational support only (control)
Number of subjects: 600
Study: 23815384

Group type: EXPERIMENTAL
Intervention: FOV 50°
Number of subjects: 0

Group type: COMPARATOR
Intervention: FOV 100°
Number of subjects: 0
Study: 21793388

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with modern rehabilitation training
Number of subjects: 120

Group type: COMPARATOR
Intervention: Modern rehabilitation training
Number of subjects: 120
Study: 19010579

Group type: EXPERIMENTAL
Intervention: Medical Emergency Team (MET) system
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control hospitals (without MET system)
Number of subjects: 23
Study: 17599843

Group type: EXPERIMENTAL
Intervention: 800 microg of vaginal misoprostol on treatment day 1
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: Second dose of misoprostol if expulsion was incomplete on day 3
Number of subjects: 473

Group type: COMPARATOR
Intervention: No intervention (neither indicator present) on day 8
Number of subjects: 473
Study: 15240627

Group type: EXPERIMENTAL
Intervention: Variable infusion rate (3 kcal/min for the first 15 min, then 0.71 kcal/min for the next 105 min)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Constant infusion rate (1 kcal/min from t = 0 to 120 min)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Variable infusion rate
Number of subjects: 16

Group type: COMPARATOR
Intervention: Constant infusion rate
Number of subjects: 16
Study: 12182779

Group type: EXPERIMENTAL
Intervention: Polylactic acid mesh implantation
Number of subjects: 39

Group type: COMPARATOR
Intervention: Standard treatment (without mesh)
Number of subjects: 39
Study: 9833910

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81

Group type: COMPARATOR
Intervention: Ursodeoxycholic acid and Placebo
Number of subjects: 81
Study: 7661121

Group type: EXPERIMENTAL
Intervention: Sucrose polyester (SPE; 12.4 g/d)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Sucrose polyester (SPE; 3 g/d)
Number of subjects: 74
Study: 2759809

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 104
Study: 799564

Group type: EXPERIMENTAL
Intervention: Propranolol or Pindolol (acute and chronic administration)
Number of subjects: 2
Study: 30967530

Group type: EXPERIMENTAL
Intervention: Intense exercise (n = 35)
Number of subjects: 70

Group type: COMPARATOR
Intervention: No exercise (n = 35)
Number of subjects: 70
Study: 28287798

Group type: EXPERIMENTAL
Intervention: Cognitive anxiety sensitivity treatment (CAST) plus cognitive bias modification for anxiety sensitivity (CBM-I)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Health information condition plus sham cognitive bias modification for anxiety sensitivity (CBM)
Number of subjects: 74
Study: 25953971

Group type: EXPERIMENTAL
Intervention: Home-based diabetes symptom self-management education (8 weekly in-home sessions + 8 biweekly support calls)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Wait-listed control condition
Number of subjects: 72
Study: 22459260

Group type: EXPERIMENTAL
Intervention: PRO‐SELF(©) Plus Pain Control Program (PCP), a 10-week intervention
Number of subjects: 39

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 39
Study: 22110714

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 0
Study: 17923131

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate challenge test (CCCT)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Exogenous FSH ovarian reserve test (EFORT)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Basal AMH, basal FSH, basal inhibin B, antral follicle count (AFC), and basal volume of the ovaries
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Standard IVF treatment
Number of subjects: 110
Study: 16197663

Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 4011

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4011
Study: 11843734

Group type: EXPERIMENTAL
Intervention: Glycopyrronium 2 microg x kg(‐1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 0
Study: 9584817

Group type: EXPERIMENTAL
Intervention: High carbohydrate diet (Carbo: > or = 150g/day for 3 days)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Candy diet (six Snickers candy bars per day for 3 days)
Number of subjects: 354

Group type: COMPARATOR
Intervention: Usual diet (Ad Lib)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: All groups (Carbo, Candy, Ad Lib)
Number of subjects: 354
Study: 7703814

Group type: EXPERIMENTAL
Intervention: Life Education drug education programme (5 consecutive years)
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Conventional school-based drug education (control group)
Number of subjects: 3000
Study: 2697568

Group type: EXPERIMENTAL
Intervention: Multicentre randomized clinical trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Independent scientifically based research organizations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmaceutical industry involvement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Critique of trial design
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CABRI trial
Number of subjects: 0
Study: 1013671

Group type: EXPERIMENTAL
Intervention: mexiletine (250 mg 8‐hourly)
Number of subjects: 40

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study: 30099547

Group type: EXPERIMENTAL
Intervention: Zolpidem (10 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 26916879

Group type: EXPERIMENTAL
Intervention: Very Low Nicotine Content (VLNC) cigarettes (0.4 to 2.4 mg/g nicotine, 9 to 13 mg tar)
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Moderate Nicotine Content (5.2 mg/g nicotine, 9 mg tar)
Number of subjects: 403

Group type: COMPARATOR
Intervention: Normal Nicotine Content (NNC) cigarettes (15.8 mg/g, 9 mg tar)
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Very Low Nicotine Content (VLNC) cigarettes
Number of subjects: 403
Study: 24626998

Group type: EXPERIMENTAL
Intervention: CRT-D implantation
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: CRT-D implantation with GFR <60 mL/min/1.73 m²
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: CRT-D implantation with GFR ≥60 mL/min/1.73 m²
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: CRT-D recipients with CI-AKI
Number of subjects: 98

Group type: COMPARATOR
Intervention: CRT-D recipients without CI-AKI
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: CI-AKI as a risk factor
Number of subjects: 98
Study: 22320241

Group type: EXPERIMENTAL
Intervention: Sirolimus (SRL)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Cyclosporine (CsA)
Number of subjects: 132
Study: 19786879

Group type: EXPERIMENTAL
Intervention: Hearing-aid use for 6 months
Number of subjects: 32

Group type: COMPARATOR
Intervention: Long-term hearing-aid use
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Visual task with emotionally positive and neutral pictures
Number of subjects: 32
Study: 18795715

Group type: EXPERIMENTAL
Intervention: M2-pyruvate-kinase concentration measurement
Number of subjects: 0
Study: 15729065

Group type: EXPERIMENTAL
Intervention: IPCfoot+calf and aspirin (75 mg)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Aspirin (75 mg) alone
Number of subjects: 41
Study: 11909881

Group type: EXPERIMENTAL
Intervention: Endurance exercise session (ES) - 40 minutes of cycling at 75% maximum heart rate
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Resistance exercise session (RS) - 3 sets of 10 repetitions of eight exercises
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control session (CS) - no exercise
Number of subjects: 30
Study: 9748878

Group type: EXPERIMENTAL
Intervention: Inhalation of berodual sol 3.5 ml/day (1.75 mg phenoterol + 0.875 mg ipratropium bromide)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhalation of berodual sol 7 ml/day (3.5 mg phenoterol + 1.75 mg ipratropium bromide)
Number of subjects: 0
Study: 7853434

Group type: EXPERIMENTAL
Intervention: Gentamicin 30 mg/kg/day
Number of subjects: 79

Group type: COMPARATOR
Intervention: Nalidixic acid 60 mg/kg/day
Number of subjects: 79
Study: 2668464

Group type: EXPERIMENTAL
Intervention: Ambulatory blood pressure readings
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Office blood pressure readings
Number of subjects: 2000
Study: 1233124

Group type: EXPERIMENTAL
Intervention: Selective gastric vagotomy and pyloroplasty (SGV+D)
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Parietal cell vagotomy (PCV) without drainage
Number of subjects: 448
Study: 31751936

Group type: EXPERIMENTAL
Intervention: Enteric-coated sodium bicarbonate (ENT)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Delayed-release sodium bicarbonate (DEL)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sodium bicarbonate (all forms)
Number of subjects: 14
Study: 30480353

Group type: EXPERIMENTAL
Intervention: Moderate-intensity endurance training (END; n = 10)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Low-volume high-intensity interval training (HIIT; n = 11)
Number of subjects: 21
Study: 27987228

Group type: EXPERIMENTAL
Intervention: Xen2174 2.5 mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 25204316

Group type: EXPERIMENTAL
Intervention: 2.9 g of eicosapentaenoic acid plus docosahexaenoic acid for 12 weeks
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 38
Study: 23158805

Group type: EXPERIMENTAL
Intervention: Intent to use long-acting reversible contraception (LARC)
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Not trying for pregnancy at time of conception
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: No desire for another pregnancy within 2 years
Number of subjects: 800
Study: 21455709

Group type: EXPERIMENTAL
Intervention: D-cycloserine (125 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 19081225

Group type: EXPERIMENTAL
Intervention: Self-focused attention and safety behaviors experiment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Video feedback experiment
Number of subjects: 0
Study: 17355022

Group type: EXPERIMENTAL
Intervention: Marmot operation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional laminectomy
Number of subjects: 70
Study: 14760802

Group type: EXPERIMENTAL
Intervention: Blind subacromial injection of 20 mg triamcinolone (Group 1, n = 20)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Sonographic guided injection of 20 mg triamcinolone (Group 2, n = 21)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (Group 1)
Number of subjects: 41
Study: 11433902

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 51

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 51
Study: 9503046

Group type: EXPERIMENTAL
Intervention: 0.5 microgram calcitriol plus 500 mg calcium daily for 6 months
Number of subjects: 26

Group type: COMPARATOR
Intervention: 800 IU cholecalciferol and 1000 mg calcium daily for 6 months
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both groups (calcitriol and cholecalciferol)
Number of subjects: 26
Study: 7995063

Group type: EXPERIMENTAL
Intervention: Topical 0.02% mitomycin C for 5 min at the completion of surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: NaCl 0.9% instead of mitomycin C
Number of subjects: 40
Study: 31686586

Group type: EXPERIMENTAL
Intervention: ORIF with arthroscopic debridement
Number of subjects: 50

Group type: COMPARATOR
Intervention: ORIF without arthroscopic debridement
Number of subjects: 50
Study: 29593017

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) plus on-demand gastrocaine
Number of subjects: 132

Group type: COMPARATOR
Intervention: Waiting list to EA plus on-demand gastrocaine
Number of subjects: 132
Study: 25953327

Group type: EXPERIMENTAL
Intervention: Venlafaxine (375 mg/day)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Imipramine (blood level 200-300 ng/ml)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 40
Study: 24445180

Group type: EXPERIMENTAL
Intervention: Risk Avoidance (RA) program
Number of subjects: 1187

Group type: EXPERIMENTAL
Intervention: Risk Reduction (RR) program
Number of subjects: 1187

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 1187
Study: 22470921

Group type: EXPERIMENTAL
Intervention: Vatreptacog alfa (5, 10, 20, 40, and 80 µg kg(‐1))
Number of subjects: 51

Group type: COMPARATOR
Intervention: Recombinant FVIIa (rFVIIa) at 90 µg kg(‐1)
Number of subjects: 51
Study: 20166794

Group type: EXPERIMENTAL
Intervention: Aripiprazole 10 mg/day
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Aripiprazole 30 mg/day
Number of subjects: 302

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302
Study: 18083724

Group type: EXPERIMENTAL
Intervention: Specialist osteoporosis nurses training care home staff
Number of subjects: 5637

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 5637
Study: 16497602

Group type: EXPERIMENTAL
Intervention: Guía+ITEMs (individually timed educational messages)
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Guía+ITEMs+a mood management course
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Guía (standard smoking cessation guide)
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Guía+ITEMs
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Participants with past MDEs
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Participants with current MDEs
Number of subjects: 4000
Study: 12930193

Group type: EXPERIMENTAL
Intervention: Cessation Training (CT, n = 7)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Maintenance Training (MT, n = 8)
Number of subjects: 15
Study: 10716460

Group type: EXPERIMENTAL
Intervention: High dose heparin (300 IU/kg)
Number of subjects: 584

Group type: COMPARATOR
Intervention: Low dose heparin (0 or 5,000 IU)
Number of subjects: 584
Study: 9184580

Group type: EXPERIMENTAL
Intervention: Adenosine (2 mg/min)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 30
Study: 8263864

Group type: EXPERIMENTAL
Intervention: Postoperative fluid instillation (1-2 L)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Control group (no fluid instillation)
Number of subjects: 137
Study: 2993733

Group type: EXPERIMENTAL
Intervention: Wheat bran (35 g)
Number of subjects: 7
Study: 31605203

Group type: EXPERIMENTAL
Intervention: 20 Hz stimulation
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 100 Hz stimulation
Number of subjects: 19
Study: 29508539

Group type: EXPERIMENTAL
Intervention: Therapist-delivered cognitive behavioural therapy
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Web-based cognitive behavioural therapy
Number of subjects: 52

Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 52
Study: 27170728

Group type: EXPERIMENTAL
Intervention: OJ with 5.5 g added orange pomace fiber (OPF)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (isocaloric sugar-matched)
Number of subjects: 36
Study: 24950270

Group type: EXPERIMENTAL
Intervention: Perineal low rectal dissection
Number of subjects: 100

Group type: COMPARATOR
Intervention: Abdominal low rectal dissection
Number of subjects: 100
Study: 22589080

Group type: EXPERIMENTAL
Intervention: Non-pharmacological intervention delivered by family members
Number of subjects: 287

Group type: COMPARATOR
Intervention: Standard management
Number of subjects: 287
Study: 19829124

Group type: EXPERIMENTAL
Intervention: Iopromide (low-osmolar) contrast media
Number of subjects: 0

Group type: COMPARATOR
Intervention: Iodixanol (iso-osmolar) contrast media
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose N-acetylcysteine (1200 mg intravenously during the procedure and 1200 mg orally two times daily for the next 48 h after percutaneous coronary intervention)
Number of subjects: 0
Study: 17276271

Group type: COMPARATOR
Intervention: Conventional ultrasound mode (US)
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: Torsional mode
Number of subjects: 525
Study: 16137113

Group type: EXPERIMENTAL
Intervention: 500 mg docosahexaenoic acid (DHA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 400 mg 5‐methyl‐tetra‐hydro‐folate (5‐MTHF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of 500 mg DHA and 400 mg 5‐MTHF
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11875284

Group type: EXPERIMENTAL
Intervention: Stimulant treatment
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206
Study: 10449958

Group type: EXPERIMENTAL
Intervention: 0.05% all‐trans‐retinoic acid (RA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2% 2‐hydroxy‐5‐octanoyl benzoic acid (beta‐lipohydroxy acid, LSA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10% glycolic acid (GA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 0
Study: 7598525

Group type: COMPARATOR
Intervention: iC3b-coated erythrocytes
Number of subjects: 18

Group type: COMPARATOR
Intervention: IgG-coated erythrocytes
Number of subjects: 18
Study: 2151757

Group type: EXPERIMENTAL
Intervention: Ondansetron (GR38032F)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 373852

Group type: EXPERIMENTAL
Intervention: Salbutamol given by intermittent positive-pressure breathing (IPPB) for three minutes
Number of subjects: 19

Group type: COMPARATOR
Intervention: Salbutamol given intravenously (500 microgram injection)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Salbutamol given by intermittent positive-pressure breathing (IPPB)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both treatments (IPPB and intravenous)
Number of subjects: 19
Study: 31684705

Group type: EXPERIMENTAL
Intervention: Active Recovery (AR)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Neuromuscular Electrical Stimulation (NMES)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Foam Rolling (FR)
Number of subjects: 45
Study: 30112581

Group type: EXPERIMENTAL
Intervention: Neural mobilization (NM) exercises targeting the median, musculocutaneous, femoral, and saphenous nerve, performed twice daily for 4-8 weeks.
Number of subjects: 21

Group type: COMPARATOR
Intervention: Gentle joint mobilization exercises targeting the same joints (Control group).
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Neural mobilization (NM) exercises (same as above).
Number of subjects: 21
Study: 27506836

Group type: EXPERIMENTAL
Intervention: 0.625mg/d conjugated equine estrogens (CEE) for those with prior hysterectomy (mean 7.1 years)
Number of subjects: 4156

Group type: EXPERIMENTAL
Intervention: CEE with 2.5mg/d medroxyprogesterone acetate for those without prior hysterectomy (mean 5.4 years)
Number of subjects: 4156

Group type: EXPERIMENTAL
Intervention: Hormone therapy in women aged 65-79 years
Number of subjects: 4156

Group type: COMPARATOR
Intervention: Matching placebos
Number of subjects: 4156
Study: 25888828

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care intervention (test groups)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care intervention (test 1 group)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care intervention (test 2 group)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 162
Study: 24004621

Group type: EXPERIMENTAL
Intervention: Subgingival scaling/root planning (SRP)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Occlusal adjustment
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combination of SRP and occlusal adjustment
Number of subjects: 18
Study: 21389041

Group type: EXPERIMENTAL
Intervention: Higher serum retinol concentrations at baseline (quintile 5)
Number of subjects: 29004

Group type: EXPERIMENTAL
Intervention: Highest quintile of serum retinol at both baseline and 3 years (quintile 5/quintile 5)
Number of subjects: 29004
Study: 19178509

Group type: EXPERIMENTAL
Intervention: GIP infusion at a rate of 2 pmol/kg/min for 4 h
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo infusion for 4 h
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: GLP‐1 infusion at a rate of 1 pmol/kg/min for 4 h
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: GLP‐1 (at 1 pmol/kg/min) with GIP (at 2 pmol/kg/min)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ad libitum energy intake after all four infusions
Number of subjects: 12
Study: 17102935

Group type: EXPERIMENTAL
Intervention: Intervention not specified, but involves three treatments for borderline personality disorder (BPD).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Assessors diagnosing BPD and comorbid diagnoses.
Number of subjects: 0
Study: 15103752

Group type: COMPARATOR
Intervention: T-tube
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Pressure Support Ventilation (PSV) 8 cm H2O
Number of subjects: 260
Study: 11032702

Group type: COMPARATOR
Intervention: NN703 (tabimorelin) 3.0 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: NN703 (tabimorelin) 6.0 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: NN703 (tabimorelin) 12.0 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: NN703 (tabimorelin) 1.5 mg/kg
Number of subjects: 0
Study: 9306740

Group type: EXPERIMENTAL
Intervention: Portable Fatigue Meter (PFM)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Distance between the PFM and the eyes
Number of subjects: 2

Group type: COMPARATOR
Intervention: Room illumination
Number of subjects: 2
Study: 8339398

Group type: EXPERIMENTAL
Intervention: Scopolamine (low doses, transdermal patch)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 3555041

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (750 mg orally every 12 hours)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Cefotaxime (2.0 g intravenously every 8 hours)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin and Cefotaxime combined cure rate
Number of subjects: 56